
I am an environmental toxicologist and the AstraZeneca global lead for the development of innovative science to support future environmental risk assessments and secure the environmental safety (eco-toxicology) of pharmaceuticals; fundamental for sustainability.
As a comparative physiologist and expert fish biologist, I lead the mode-of-action driven investigations that provide a mechanistic understanding of how human pharmaceuticals may work in animals so as to better predict the possible risks to wildlife.
I am passionate about research to drive the aquatic safety testing paradigm away from animal studies. I do this by investigating new alternative approaches such as using cells to build 3D organoid tissues in culture. At AstraZeneca I am the global lead for the 3Rs (reduction, replacement and refinement) of animal studies and I am proud to chair the prestigious AstraZeneca awards that help share the innovation from these teams.
I am privileged to work with some of the leading academics and opinion formers in my field and have published more than 65 scientific papers. I work extensively supporting early career scientists and I am an Honorary Associate Professor in the College of Life and Environmental Sciences at the University of Exeter. In 2021 I joined the independent Hazardous Substances Advisory Committee for the UK Government, bringing expertise in New Approach Methods to support future chemical assessments.
By collaborating with some of the best scientists and leaders in academia, regulators and industry I am working towards finding better ways to predict the potential impacts of chemicals in the environment.

Hon Associate Professor, University of Exeter.

Hazardous Substances Advisory Committee (HSAC)

AstraZeneca Council for Science and Animal Welfare

CURRENT ROLE
2021
2021
2020